Protagonist Therapeutics PTGX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's total liabilities?
- Protagonist Therapeutics (PTGX) reported total liabilities of $41.99M in Q1 2026.
- How has Protagonist Therapeutics's total liabilities changed year-over-year?
- Protagonist Therapeutics's total liabilities decreased by 20.9% year-over-year, from $53.08M to $41.99M.
- What is the long-term trend for Protagonist Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's total liabilities has grown at a 3.6% compound annual growth rate (CAGR), from $44.86M to $53.48M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.